Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
<div><p>The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals of personalized medicine, a c...
Saved in:
| Main Author: | Nagham N. Hindi (18526815) (author) |
|---|---|
| Other Authors: | Jamil Alenbawi (14056978) (author), Georges Nemer (295984) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
by: Amina Kamar (295977)
Published: (2021) -
LDL-C Targets in Secondary Prevention: How Low Should We Go?
by: Karim Bayoumy (3496688)
Published: (2019) -
The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
by: Ilhame Diboun (3522413)
Published: (2022) -
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
by: Elysia M Alvarez (12229352)
Published: (2022) -
The role of protective genetic variants in modulating epigenetic aging
by: Yosra Bejaoui (8552574)
Published: (2025)